Acta Med. 1999, 42: 93-96

https://doi.org/10.14712/18059694.2019.150

Is Factor V Leiden a Risk Factor for Fetal Loss?

Petr Dulíčeka, Ladislav Chrobáka, Ivo Kalousekb, Lenka Pešavovác, Miroslav Peckaa, Pravoslav Stránskýd

aUniversity Teaching Hospital in Hradec Králové, Department of Clinical Haematology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Obstetrics and Gynecology, Hradec Králové, Czech Republic
cUniversity Teaching Hospital in Hradec Králové, Department of Clinical Biochemistry, Hradec Králové, Czech Republic
dCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Medical Biophysics, Hradec Králové, Czech Republic

Received September 1, 1999
Accepted September 1, 1999

References

1. Berkane A, Verdy E, Heim A et al. Does the Q506 mutation of factor V contribute to fetal loss or stillbirth? Thromb Haemost 1997; Suppl. 1:759-60.
2. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-7. <https://doi.org/10.1038/369064a0>
3. Brenner B. Inherited thrombophilia and pregnancy loss. Thromb Haemost 1999; 82:634-40.
4. Brenner B, Mandel H, Lanir A et al. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997; 97:55l-4. <https://doi.org/10.1046/j.1365-2141.1997.882901.x>
5. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphism in women with fetal loss. Blood 1998; 92(Suppl. 1):558a.
6. Conard J, Horellou MH, VanDreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S. Thromb Haemost 1990; 63:319-20.
7. Dahlbäck B. Resistance to activated protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Thromb Haemost 1995; 73:739-42.
8. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85:607-14.
9. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C; prediction of a cofactor to activated protein C. Proc Natl Acad Sci U.S.A 1993; 90:1004-8. <https://doi.org/10.1073/pnas.90.3.1004> <PubMed>
10. Franks AL, Atrash HK, Lawson HW, Colberg KS. Obstetrical pulmonary embolism mortality. United States 1970-85. Am J Public Health 1990; 80:720-2. <https://doi.org/10.2105/AJPH.80.6.720>
11. Grandone E, Margaglione M, Colaizzo D et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997; 77:822-4.
12. Green D, Maliekel K, Sushko E et al. Activated protein C resistance in cancer patients. Thromb Haemost 1997; Suppl.1:316.
13. Hellgren M, Tengborn L, Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: Experience of treatment with heparin and antithrombin. Gynecol Obstet Invest 1982; 14:127-41. <https://doi.org/10.1159/000299460>
14. Hillarp A, Dahlbäck B. Activated protein C resistance. Vessels 1997; 3:3-10.
15. Högberg U. Maternal mortality in Sweden. Thesis,Umea,Sweden 1985;118.
16. Kjellberg U, Andersson NE, Rosen S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81:527-31.
17. Kotwal J, Saxena R, Mohanty S et al. APC resistance in recurrent fetal loss in the Indian population. Br J Haematol 1998; 103:588. <https://doi.org/10.1046/j.1365-2141.1998.01091.x>
18. Lindqvist PG, Svensson PJ, Maršál K, Grenner L, Luterkort M, Dahlbäck B. Activated protein C resistance (f V Q506) and pregnancy. Thromb Haemost 1999; 81:532-7.
19. Meinardi JR, Henkens CMA, Heringa et al. Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practise. Blood Coag Fibrinol 1997; 8:152-4. <https://doi.org/10.1097/00001721-199703000-00011>
20. Olivieri O, Friso S, Manzato F et al. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol 1995; 91:465-70. <https://doi.org/10.1111/j.1365-2141.1995.tb05323.x>
21. Preston FE, Rosendaal FR, Walker ID et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348:913-16. <https://doi.org/10.1016/S0140-6736(96)04125-6>
22. Ridker PM, Miletich JP, Buring JE et al. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998; 28:1000-3. <https://doi.org/10.7326/0003-4819-128-12_Part_1-199806150-00007>
23. Sanson BJ, Friedrich PW, Simioni P et al. The risk of abortion and stillbirth in antithrombin-protein C and protein S deficient women. Thromb Haemost 1996; 75:387-8.
24. Stirrat GM. Recurrent miscarriage I: definition and epidemiology. Lancet 1990; 336:673-5. <https://doi.org/10.1016/0140-6736(90)92159-F>
25. Svensson PJ, Dahlbäck. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330:517-22. <https://doi.org/10.1056/NEJM199402243300801>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive